Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
LB PHARMACEUTICALS INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
LB PHARMACEUTICALS INCListing unverified | Buy | $30M | conv 79ClusterFirst in 12mo | SEC | |
LB PHARMACEUTICALS INCListing unverified | Buy | $10M | conv 70ClusterFirst in 12mo | SEC | |
LB PHARMACEUTICALS INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
DYNAVAX TECHNOLOGIES CORPListing unverified | Sell | $12.1M | SEC | ||
DYNAVAX TECHNOLOGIES CORPListing unverified | Sell | $10.3M | SEC |